EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prevention and Management of Infectious Complications in Pediatric Patients With Cancer: A Survey Assessment of Current Practices Across Children's Oncology Group Institutions

Leonora R Slatnick, David Hoogstra, Brian T Fisher, Joshua Wolf, Etan Orgel iD, C Nathan Nessle iD, Pratik A Patel, Tamara P Miller iD, Jennifer Wilkes, L Lee Dupuis iD, Erin Goode, Kasey Jackson und 17 weitere

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31532 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Leonora R Slatnick und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Primary Children's Hospital, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Neoplasms, Antibiotic Prophylaxis, Practice Patterns, Physicians'. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

While clinical practice guidelines (CPGs) for pediatric oncology infection prophylaxis and management exist, few data describe actual management occurring at pediatric oncology centers.

Methods

An electronic survey querying infection management practices in nontransplant pediatric oncology patients was iteratively created by the Children's Oncology Group (COG) Cancer Control and Supportive Care Infectious Diseases Subcommittee and sent to leaders at all COG institutions, limiting each site to one response to represent their institution.

Results

The response rate was 57% (129/227 institutions). Many sites reported utilizing COG‐endorsed CPGs for antibacterial (76%) and antifungal prophylaxis (74%), and fever and neutropenia (FN, 64%). Most institutions reported using antimicrobial prophylaxis for patients with acute myeloid leukemia (88% antibacterial, 100% antifungal) and relapsed acute lymphoblastic leukemia (82% antibacterial, 95% antifungal). Definitions of fever, phagocyte recovery, and antibiotic duration in febrile patients varied. Most institutions administer empiric broad‐spectrum antibiotics for nonneutropenic fever, although 14% reported withholding antibiotics based on initial clinical status or risk stratification tools. Most respondents reported (70%) admitting FN patients for at least 48 h, however 15% have low‐risk FN protocols allowing outpatient management. FN patients remain admitted on antibiotics through count recovery in 50% of institutions, whereas the others employed various early discharge/early antibiotic discontinuation strategies.

Conclusions

There is often consistency but also substantial variability in reported antimicrobial prophylaxis strategies and management of patients with fever and represents an opportunity for implementation studies to standardize application of CPG recommendations and randomized trials to advance evidence where knowledge gaps exist.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntibiotic ProphylaxisPractice Patterns, Physicians'HumansChildSurveys and QuestionnairesPractice Guidelines as TopicAnti-Bacterial Agents

Stichwörter der Autor:innen

Children's Oncology Groupfebrile neutropeniafungal prophylaxisinfectious complicationspediatric oncologysupportive care

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pediatrics, Primary Children's Hospital, Salt Lake City, Utah, USA.
  • Department of Pediatrics, Helen Devos Children's Hospital, Grand Rapids, Michigan, USA.
  • Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Departments of Infectious Diseases and Pediatrics, St Jude Children's Research Hospital, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Cancer and Blood Disease Institute, Children's Hospital of Los Angeles Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Division of Pediatric Hematology Oncology, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA.

ORCID-Profile: Etan Orgel, C Nathan Nessle, Tamara P Miller, L Lee Dupuis, Caitlin Elgarten, Catherine Aftandilian, Joel Thompson, Sarah Alexander, Melissa P Beauchemin, Jennifer A Belsky, Zachary D Prudowsky, Jenna Rossoff, Alexandra M Walsh, Rebecca Richards, Daniel K Choi, Christopher C Dvorak, Adam J Esbenshade

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Slatnick, L. R., Hoogstra, D., Fisher, B. T., Wolf, J., Orgel, E., Nessle, C. N., Patel, P. A., Miller, T. P., Wilkes, J., Dupuis, L. L., Goode, E., Jackson, K., Willis, D. N., Elgarten, C., Aftandilian, C., Thompson, J., Alexander, S., Beauchemin, M. P., Belsky, J. A., …, & Esbenshade, A. J. (2025). Prevention and Management of Infectious Complications in Pediatric Patients With Cancer: A Survey Assessment of Current Practices Across Children's Oncology Group Institutions. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31532

Vancouver

Slatnick LR, Hoogstra D, Fisher BT, Wolf J, Orgel E, Nessle CN, et al. Prevention and Management of Infectious Complications in Pediatric Patients With Cancer: A Survey Assessment of Current Practices Across Children's Oncology Group Institutions. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31532

BibTeX
@article{Slatnick2025,
  author = {Slatnick, Leonora R and Hoogstra, David and Fisher, Brian T and Wolf, Joshua and Orgel, Etan and Nessle, C Nathan and Patel, Pratik A and Miller, Tamara P and Wilkes, Jennifer and Dupuis, L Lee and Goode, Erin and Jackson, Kasey and Willis, Daniel N and Elgarten, Caitlin and Aftandilian, Catherine and Thompson, Joel and Alexander, Sarah and Beauchemin, Melissa P and Belsky, Jennifer A and Hess, Jennifer and Prudowsky, Zachary D and Guinipero, Terri and Rossoff, Jenna and Demedis, Jenna and Walsh, Alexandra M and Richards, Rebecca and Choi, Daniel K and Dvorak, Christopher C and Esbenshade, Adam J},
  title = {Prevention and Management of Infectious Complications in Pediatric Patients With Cancer: A Survey Assessment of Current Practices Across Children's Oncology Group Institutions},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31532}
}
Kostenlos starten →